Loading organizations...
§ Private Profile · Monheim, Bayern, Germany
Biotechnology company developing tailor-made biocatalysts and enzyme processes for industrial, fine chemical, and pharmaceutical applications.
Based in Monheim am Rhein, Germany, evocatal develops biocatalysts and enzyme-based chemical processes for industrial applications within the pharmaceutical and fine chemical sectors. The biotechnology company specializes in engineering tailor-made enzymes used to produce complex low-molecular weight compounds, operating as an active participant in regional scientific networks such as IWBio and CLIB2021. To support its ongoing research, enzyme development, and manufacturing capacities, the enterprise has secured multiple financing rounds, including a €3.5 million Series B round and an additional €2 million in follow-on funding. The organization's financial backing comes from a syndicate of notable venture capital investors and private backers, featuring High-Tech Gründerfonds, Sirius Seedfonds Düsseldorf, and Roland Oetker. Evocatal was originally founded in 2006 as a spin-off from the Institute for Molecular Enzyme Technology at the University of Düsseldorf by Dr. Thorsten Eggert alongside two university professors.
evocatal has raised $7.1M across 2 funding rounds.
evocatal has raised $7.1M in total across 2 funding rounds.
evocatal has raised $7.1M in total across 2 funding rounds.
evocatal's investors include Prof. Riesner, Roland Oetker, High-Tech Grunderfonds, LANXESS, NRW.BANK, Sirius Venture Partners.
evocatal has raised $7.1M across 2 funding rounds. Most recently, it raised $4.6M Series B in June 2013.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 27, 2013 | $4.6M Series B | — | Prof. Riesner, Roland Oetker, High Tech Grunderfonds, Lanxess, NRW.BANK, Sirius Venture Partners | Announced |
| Jul 6, 2010 | $2.5M Series B | Roland Oetker | Prof. Riesner, High Tech Grunderfonds, Sirius Venture Partners | Announced |